PINL:GRPOF - Post by User
Comment by
Golddetectoron Jul 12, 2021 8:25am
205 Views
Post# 33529014
RE:NEWSSSSS
RE:NEWSSSSS Three main points from this news release:
1. The on going trial is doing well otherwise it won't be expanded in the 1st place.
2. QIXLEEF is now offered as alternative to more than morphine which widens the market opportunities.
3. the last paragraph indicates that there is a resistance to the use of these products by physicians. Ie immediate market needs to alternative which increases demand for QIXLEEF.
All in all looks great to me.